Effect of oestrogen replacement therapy on serum lipid profile

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 43, Issue 3, 2003, Pages 213-216

  Nanda, Smiti ^a   Gupta, Neeta ^a   Mehta, Harish C ^a   Sangwan, Krishna ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hormone replacement therapy; Menopause; Oestrogen replacement therapy; Serum lipid profile; Serum triglycerides

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; HYSTERECTOMY; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; TRIGLYCERIDES;

EID: 0038489194     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0004-8666.2003.00068.x     Document Type: Article

References (16)

1. Tikkanen MJ. Estrogens, progestins and lipid metabolism. Maturitas. 1996; 23: S51-55.
2. Johnson R. Menopause and hormone replacement therapy. Med Clin North Am. 1998; 82: 297-320.
3. Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinic Program Follow-up Study. Circulation. 1987; 75: 1102-1109.
4. Henderson BE, Paganini Hull A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol. 1988; 159: 312-317.
5. Garcia L, Hernandez I, Cervera Aguilar R, Ayala AR. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism]. Ginecol Obstet Mex. 2001; 69: 351-354 (in Spanish).
6. Crook D, Seed M. Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids. Baillieres Clin Endocrinol Metab. 1990; 4: 851-876.
7. Gokmen O, Yapar Eyi EG. Hormone replacement therapy and lipid-lipoprotein concentrations. Eur J Obstet Gynecol Reprod Biol. 1999; 85: 31-41.
8. Araujo DA, Farias ML, Andrade AT. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Climacteric. 2002; 5: 286-292.
9. Sendag F, Karadadas N, Ozsener S, Bilgin O. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women. Arch Gynecol Obstet. 2002; 266: 38-43.
10. Crook D, Cust MP, Gangar KF et al. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol. 1992; 166: 950-955.
11. Adami S, Rossini M, Zamberlan N, Bertoldo F, Dorizzi R, Lo Cascio V. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women. Maturitas. 1993; 17: 191-196.
12. Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Clin Pharmacol. 1998; 45: 170-172.
13. The Writing Group for the PEPI Trial. Effect of estrogen or estrogen/progesten regimens on heart disease risk factors in post menopausal women. The Postmenopausal Estrogen/Progesten Interventions (PEPI) Trial. The Writing Group for PEPI Trial. JAMA. 1995; 273: 199-208.
14. Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentration. Obstet Gynecol. 1994; 84: 222-226.
15. Man RY, Ting LK, Fan S, Lau MM, Siow YL, Chung YH, OK. Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women. Mol Cell Biochem. 2001; 225: 129-134.
16. Cauley JA, La Porte RE, Kuller LH, Bates M, Sandler RB. Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver functions. Atherosclerosis. 1983; 49: 31-39.